实用医学杂志 ›› 2021, Vol. 37 ›› Issue (4): 472-476.doi: 10.3969/j.issn.1006⁃5725.2021.04.011

• 临床研究 • 上一篇    下一篇

COSSH⁃ACLF 评分联合血清白细胞介素⁃37水平对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值

韩成美,任运华,丁雷   

  1. 山东第一医科大学附属济南人民医院感染科(济南 271100)
  • 出版日期:2021-02-25 发布日期:2021-02-25
  • 基金资助:
    山东省科技发展计划项目(编号:2016ZRC10136)

The evaluation value of COSSH⁃ACLF score combined with serum IL⁃37 level in short⁃term prognosis of patients with chronic hepatitis B Virus(HBV)associated with acute liver failure

HAN Chengmei,REN Yunhua,DING Lei   

  1. Department of Infection,Ji′nan People′s Hospital Affiliated to Shandong First Medical Universi⁃ ty,Ji′nan 271100,China

  • Online:2021-02-25 Published:2021-02-25

摘要:

目的 探讨中国重型乙型肝炎研究组⁃慢加急性肝衰竭(COSSH⁃ACLF)评分联合血清白细胞介 ⁃37(IL⁃37)水平预测乙肝病毒感染相关慢加急性肝功能衰竭(HBV⁃ACLF)患者近期预后的价值。方法 2018年1月至2020年6月我院住院病房收治的129例HBV⁃ACLF患者(HBV⁃ACLF组)、同期我院消化内科 门诊收治的 53 例慢性乙型肝炎病毒感染患者(CHB 组)和门诊接诊的 50 例健康志愿者(对照组)。计算 COSSH⁃ACLF 评分,检测血清IL⁃37、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素(TBIL)、白蛋白 Alb)、胆碱酯酶(CHE)水平,收集HBV⁃ACLF 组临床资料和入院30 d 临床结局,根据临床结局分为死亡组 35例)和存活组(94例)。Logistic回归分析HBV⁃ACLF患者死亡的危险因素,受试者工作特征曲线(ROC)分析 COSSH⁃ACLF评分联合IL⁃37预测HBV⁃ACLF患者近期预后的价值。结果 HBV⁃ACLF组COSSH⁃ACLF评分、 血清IL⁃37、ALT、AST、TBIL水平高于CHB组和对照组(P<0.05),CHE、Alb低于CHB组和对照组(P<0.05)。 Logistic回归分析结果显示合并肝性脑病、低HBV⁃DNA、高COSSH⁃ACLF评分、高IL⁃37是影响HBV⁃ACLF患者 预后的危险因素(P<0.01)。ROC分析结果显示COSSH⁃ACLF评分联合IL⁃37预测HBV⁃ACLF患者预后的曲 线下面积(AUC)为 0.880、0.798、0.954,灵敏度、特异度分别为 82.86%、71.43%、91.43%;85.11%、76.60% 94.68%。结论 HBV⁃ACLF 患者 COSSH⁃ACLF 评分、血清 IL⁃37 水平显著增加,COSSH⁃ACLF 评分、IL⁃37 HBV⁃ACLF患者近期预后有关,COSSH⁃ACLF评分联合IL⁃37可提高对HBV⁃ACLF 近期预后预测准确性。

关键词:

HBV 相关慢加急性肝衰竭, 乙型肝炎病毒, 中国重型乙型肝炎研究组?慢加急性肝衰 竭评分, 白细胞介素?37, 预后

Abstract: Objective To investigate the value of Chinese group on the study of severe hepatitis B⁃cute on chronic liver failure(COSSH⁃ACLF)score combined with serum interleukin⁃37(IL⁃37)in predicting the short⁃term prognosis of patients with hepatitis B virus infection associated with hepatitis B ⁃ related acute ⁃on ⁃chronic liver failure(HBV⁃ACLF). Methods From January 2018 to June 2020,129 cases of HBV⁃ACLF patients(HBV⁃ACLF group),53 cases of chronic hepatitis B virus infection(CHB group)and 50 healthy volunteers(control group were selected from the outpatient department of gastroenterology of our hospital.The COSSH ⁃ACLF score was calculated,detected the serum level of IL⁃37,alanine aminotransferase(ALT),aspartate aminotransferase(AST), total bilirubin(TBIL),albumin(Alb)and cholinesterase(CHE). The clinical data of the HBV⁃ACLF group and the clinical outcomes on admission for 30 days were collected. According to the clinical outcomes,the patients were divided into death group(35 cases)and survival group(94 cases).Logistic regression analysis was conducted for the risk factors of death in patients with HBV ⁃ACLF. ROC analysis was conducted for the value of COSSH ⁃ ACLF score combined with IL ⁃ 37 in predicting the short ⁃ term prognosis of patients with HBV ⁃ ACLF. Results COSSH ⁃ACLF score,serum IL ⁃37,ALT,AST and TBIL level in HBV ⁃ACLF group were higher than those in CHB group and control group(< 0.05),while CHE and Alb were lower than those in CHB group and control group (< 0.05). Logistic regression analysis showed that complicated with hepatic encephalopathy,low HBV ⁃DNA high COSSH ⁃ACLF score,and high IL ⁃37 were risk factors affecting the prognosis of patients with HBV ⁃ACLF (P < 0.01). ROC analysis results showed that the area under the curve(AUC)of COSSH⁃ACLF score combined with IL ⁃37 predicted the prognosis of patients with HBV ⁃ACLF was 0.880、0.798、0.954,and the sensitivity and specificity were 82.86%,71.43%,91.43%;85.11%,76.60%,94.68%. Conclusion COSSH⁃ACLF score and serum IL⁃37 level in patients with HBV⁃ACLF are significantly increased,COSSH⁃ACLF score and IL⁃37 are related to the short⁃term prognosis of patients with HBV⁃ACLF,and COSSH⁃ACLF score combined with IL⁃37 can improve the accuracy of short⁃term prognosis prediction of HBV⁃ACLF.

Key words:

hepatitis B related acute on chronic liver failure, hepatitis B virus, chinese group on the study of severe hepatitis B?cute on chronic liver failure, interleukin?37, prognosis